| Entry |
|
|---|
| Name |
Olodaterol hydrochloride (JAN/USAN);
Striverdi respimat (TN) |
|---|
| Product |
|
|---|
| Formula |
C21H26N2O5. HCl
|
|---|
| Exact mass |
422.1609
|
|---|
| Mol weight |
422.9025
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG01058): | D10020<US> |
| Product (mixture): | D10744<JP/US> |
|
|---|
| Efficacy |
Bronchodilator, beta2-Adrenergic receptor agonist |
|---|
| Disease |
Chronic obstructive pulmonary disease [DS: H01714] |
|---|
| Comment |
Phenethylamine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Metabolism |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AC Selective beta-2-adrenoreceptor agonists
R03AC19 Olodaterol
D10020 Olodaterol hydrochloride (JAN/USAN) <US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Bronchodilators, Sympathomimetic
Olodaterol
D10020 Olodaterol hydrochloride (JAN/USAN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D10020 Olodaterol hydrochloride (JAN/USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10020
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10020
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10020
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 29
1 C5x C 11.1300 -18.6200
2 N1x N 11.1300 -17.2200
3 C8y C 12.3200 -16.5200
4 C8y C 13.5100 -17.2200
5 O2x O 13.5100 -18.6200
6 C1x C 12.3200 -19.3200
7 C8x C 12.3200 -15.1200
8 C8y C 13.5100 -14.4200
9 C8x C 14.7700 -15.1200
10 C8y C 14.7700 -16.5200
11 O5x O 9.8700 -19.3200
12 O1a O 13.5100 -13.0200
13 C1c C 15.9600 -17.2200
14 C1b C 17.1500 -16.5200
15 O1a O 15.9600 -18.6200
16 N1b N 18.3400 -17.2200
17 C1d C 19.5300 -16.5200
18 C1b C 20.7200 -17.2200
19 C8y C 21.9800 -16.5200
20 C1a C 18.8300 -15.3300
21 C1a C 20.2300 -15.3300
22 C8x C 21.9800 -15.1200
23 C8x C 23.1700 -14.4200
24 C8y C 24.3600 -15.1200
25 C8x C 24.3600 -16.5200
26 C8x C 23.1700 -17.2200
27 O2a O 25.6200 -14.4200
28 C1a C 26.8100 -15.1200
29 X Cl 26.6700 -19.5300
BOND 30
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 3 7 2
8 7 8 1
9 8 9 2
10 9 10 1
11 4 10 2
12 1 11 2
13 8 12 1
14 10 13 1
15 13 14 1
16 13 15 1 #Down
17 14 16 1
18 16 17 1
19 17 18 1
20 18 19 1
21 17 20 1
22 17 21 1
23 19 22 2
24 22 23 1
25 23 24 2
26 24 25 1
27 25 26 2
28 19 26 1
29 24 27 1
30 27 28 1
|
|---|
